Literature DB >> 20804727

Transforming acidic coiled-coil protein-3 (Tacc3) acts as a negative regulator of Notch signaling through binding to CDC10/Ankyrin repeats.

Sharon Bargo1, Ahmed Raafat, David McCurdy, Idean Amirjazil, Youmin Shu, June Traicoff, Joshua Plant, Barbara K Vonderhaar, Robert Callahan.   

Abstract

We have identified the transforming acidic coiled-coil protein-3 (Tacc3) as a binding partner for Notch4/Int3 and were able to show that it binds to the intracellular domain (ICD) of all members of the Notch receptor family. Members of the Tacc family reside at the centrosomes and associates with microtubules. Recent studies suggest that Tacc3 also contributes to the regulation of gene transcription. Tacc3 specifically interacts with the Notch4/Int3 CDC10/Ankyrin repeats and to a lesser extent, with residues C-terminal to these repeats in the ICD. Dual label immunofluorescence of mouse mammary tissue shows Tacc3 co-localizes with the Notch3 ICD. Co-immunoprecipitation of endogenous Notch and Tacc3 proteins from NIH3T3 cell extracts, lung and mammary gland confirms that these two proteins interact under physiological conditions. In addition, knock down of Tacc3 in NIH3T3 cells leads to the up-regulation of Hey2, a target gene for Notch signaling. The affinity of Tacc3 binding to Notch4/Int3 ICD is similar to that between Rbpj and Notch4/Int3 ICD. Notch4/Int3 ICD-Tacc3 interaction results in the inhibition of transcription from a Hes1-Luciferase reporter vector in COS-1 cells. The inhibition was reversed in these cells by increasing the levels of Rbpj. Taken together, these results suggest that Tacc3 is a negative regulator of the Notch signaling pathway. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20804727      PMCID: PMC2964058          DOI: 10.1016/j.bbrc.2010.08.111

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  Notch signaling in mammary development and oncogenesis.

Authors:  Robert Callahan; Sean E Egan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

2.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

3.  Activation of the human T-cell leukemia virus type I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate and by tax (p40x) occurs through similar but functionally distinct target sequences.

Authors:  M Radonovich; K T Jeang
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.

Authors:  S Rogers; R Wells; M Rechsteiner
Journal:  Science       Date:  1986-10-17       Impact factor: 47.728

5.  Growth suppression of normal mammary epithelial cells by wild-type p53.

Authors:  G R Merlo; T Venesio; D Taverna; B M Marte; R Callahan; N E Hynes
Journal:  Oncogene       Date:  1994-02       Impact factor: 9.867

6.  The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4).

Authors:  D Gallahan; R Callahan
Journal:  Oncogene       Date:  1997-04-24       Impact factor: 9.867

7.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

8.  A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.

Authors:  X J Yang; V V Ogryzko; J Nishikawa; B H Howard; Y Nakatani
Journal:  Nature       Date:  1996-07-25       Impact factor: 49.962

9.  Mouse mammary tumor gene int-3: a member of the notch gene family transforms mammary epithelial cells.

Authors:  J Robbins; B J Blondel; D Gallahan; R Callahan
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene.

Authors:  H Uyttendaele; G Marazzi; G Wu; Q Yan; D Sassoon; J Kitajewski
Journal:  Development       Date:  1996-07       Impact factor: 6.868

View more
  10 in total

1.  High Expression of TACC3 Is Associated with the Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma Patients.

Authors:  Yan Chen; Min Zhou; Xuyu Gu; Longfei Wang; Cailian Wang
Journal:  Dis Markers       Date:  2022-07-09       Impact factor: 3.464

2.  TACC3 is essential for EGF-mediated EMT in cervical cancer.

Authors:  Geun-Hyoung Ha; Jung-Lye Kim; Eun-Kyoung Breuer; Eun-Kyoung Yim Breuer
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

3.  TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.

Authors:  Yong Du; Lili Liu; Chenliang Wang; Bohua Kuang; Shumei Yan; Aijun Zhou; Chuangyu Wen; Junxiong Chen; Yue Wu; Xiangling Yang; Guokai Feng; Bin Liu; Aikichi Iwamoto; Musheng Zeng; Jianping Wang; Xing Zhang; Huanliang Liu
Journal:  Oncotarget       Date:  2016-07-05

4.  TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.

Authors:  Zhi-Rui Lin; Meng-Yao Wang; Shi-Yang He; Zhi-Ming Cai; Wei-Ren Huang
Journal:  Cell Death Dis       Date:  2018-01-22       Impact factor: 8.469

5.  TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis.

Authors:  June Wang; Shenlin Du; Wei Fan; Ping Wang; Weiqing Yang; Mingxia Yu
Journal:  Oncotarget       Date:  2017-08-24

6.  Inhibiting of TACC3 Promotes Cell Proliferation, Cell Invasion and the EMT Pathway in Breast Cancer.

Authors:  Qin Huo; Siqi Chen; Zhenwei Li; Juan Wang; Jiaying Li; Ni Xie
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

7.  Oncogenic FGFR3 gene fusions in bladder cancer.

Authors:  Sarah V Williams; Carolyn D Hurst; Margaret A Knowles
Journal:  Hum Mol Genet       Date:  2012-11-21       Impact factor: 6.150

8.  TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.

Authors:  Dong-Sheng Zhou; Hong-Bo Wang; Zhong-Guo Zhou; Yao-Jun Zhang; Qian Zhong; Li Xu; Yue-Hua Huang; Sai-Ching Yeung; Min-Shan Chen; Mu-Sheng Zeng
Journal:  Oncotarget       Date:  2015-09-15

9.  The ANK repeats of Notch-4/Int3 activate NF-κB canonical pathway in the absence of Rbpj and causes mammary tumorigenesis.

Authors:  Ahmed Raafat; Sharon Bargo; David McCurdy; Robert Callahan
Journal:  Sci Rep       Date:  2017-10-20       Impact factor: 4.379

10.  Pretreatment TACC3 expression in locally advanced rectal cancer decreases the response to neoadjuvant chemoradiotherapy.

Authors:  Wen-Juan Ma; Yang-Kui Gu; Jian-Hong Peng; Xue-Cen Wang; Xin Yue; Zhi-Zhong Pan; Gong Chen; Hai-Neng Xu; Zhong-Guo Zhou; Rong-Xin Zhang
Journal:  Aging (Albany NY)       Date:  2018-10-19       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.